Ethics approval: The study was approved by Institution Ethical Review Board.
Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury
Article first published online: 19 DEC 2012
© 2012 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd
Journal of Gastroenterology and Hepatology
Volume 28, Issue 1, pages 161–167, January 2013
How to Cite
Devarbhavi, H., Singh, R., Patil, M., Sheth, K., Adarsh, C. K. and Balaraju, G. (2013), Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury. Journal of Gastroenterology and Hepatology, 28: 161–167. doi: 10.1111/j.1440-1746.2012.07279.x
Author contributions: HD: Concept and design, acquisition of data, analysis and interpretation of data, statistical analysis, drafting and critical revision of the manuscript, study supervision. MP, KS, CKA: Acquisition of data, study supervision, drafting and critical revision of the manuscript. RS: Interpretation of data, statistical analysis, drafting and critical revision of the manuscript. Final approval of the manuscript: All authors
- Issue published online: 19 DEC 2012
- Article first published online: 19 DEC 2012
- Accepted manuscript online: 28 SEP 2012 08:32AM EST
- Manuscript Accepted: 19 SEP 2012
Table S1 Summary of clinical and laboratory characteristics of HIV infected patients with anti-TB DILI.
Table S2 Concomitant medications.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.